Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.2440
-0.0160 (-6.15%)
Sep 9, 2025, 4:35 PM BST
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 16.65 million as of September 9, 2025. Its market cap has increased by 262.61% in one year.
Market Cap
16.65M
Enterprise Value
15.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
Market Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 16.65M, a decrease of -27.71%. That is a compound annual growth rate of -8.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 16.65M | 253.76% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rolls-Royce Holdings | 90.34B |
| RELX PLC | 63.60B |
| BAE Systems | 53.02B |
| Experian | 35.81B |
| Ashtead Group | 23.45B |
| International Consolidated Airlines Group | 18.07B |
| Halma | 12.25B |
| Rentokil Initial | 9.48B |